
Dawn Health Secures €11.5 Million to Expand Digital Health Platform
Dawn Health has secured €11.5 million in funding from existing investors, including Chr. Augustinus Fabrikker, the Export and Investment Fund of Denmark (EIFO), and Trifork, announced in a press release. This investment aims to enhance the company's platform and product suite, which are designed to support global pharmaceutical companies through a SaaS model.
Since 2021, Dawn Health has focused on developing a platform tailored for the pharmaceutical industry, which has been adopted by major companies such as Merck and Novartis. The platform is utilized in areas like oncology, multiple sclerosis, and rare pediatric conditions, aiding patients in managing treatments and maintaining communication with healthcare providers.
The Dawn Platform leverages advanced AI capabilities, data analytics, and clinical integrations to improve patient outcomes and support pharma companies. This funding will allow Dawn Health to expand its market reach and continue investing in its product offerings, reinforcing its position as a trusted partner in the digital health sector.
We hope you enjoyed this article.
Consider subscribing to one of several newsletters we publish like Life AI Weekly.
Also, consider following us on social media:
More from: Healthcare & Life Sciences
Invetech and AiCella Collaborate to Enhance Cell Therapy with AI
Core Solutions and OPEN MINDS Launch AI Advisory Board for Behavioral Health
Avio Health Unveils Functional Medicine LLM for Personalized Healthcare
Novo Nordisk Foundation Allocates DKK 479 Million for AI and Health Projects
More from: Funding
DataBahn.ai Secures $17M to Enhance AI Data Pipelines
Waypoint AI Secures $3.1M Pre-Seed Funding for AI Customer Support
CRED Secures $15M to Enhance Predictive Intelligence for Enterprises
Movable Ink to be Acquired by STG
GreetEat Acquires WallStreetStats.io to Boost AI Capabilities
Subscribe to Life AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Whitepaper
Stanford HAI’s 2025 AI Index Reveals Record Growth in AI Capabilities, Investment, and Regulation
The 2025 AI Index by Stanford HAI provides a comprehensive overview of the global state of artificial intelligence, highlighting significant advancements in AI capabilities, investment, and regulation. The report details improvements in AI performance, increased adoption in various sectors, and the growing global optimism towards AI, despite ongoing challenges in reasoning and trust. It serves as a critical resource for policymakers, researchers, and industry leaders to understand AI's rapid evolution and its implications.
Read more